Cargando…
Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response
BACKGROUND: Patient-derived organoids and xenografts (PDXs) have emerged as powerful models in functional diagnostics with high predictive power for anticancer drug response. However, limitations such as engraftment failure and time-consuming for establishing and expanding PDX models followed by tes...
Autores principales: | Zhang, Feifei, Wang, Wenjie, Long, Yuan, Liu, Hui, Cheng, Jijun, Guo, Lin, Li, Rongyu, Meng, Chao, Yu, Shan, Zhao, Qingchuan, Lu, Shun, Wang, Lili, Wang, Haitao, Wen, Danyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158900/ https://www.ncbi.nlm.nih.gov/pubmed/30257718 http://dx.doi.org/10.1186/s40880-018-0329-5 |
Ejemplares similares
-
Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma
por: Zhao, Peng, et al.
Publicado: (2018) -
Xenograft tumors derived from malignant pleural effusion of the patients with non-small-cell lung cancer as models to explore drug resistance
por: Xu, Yunhua, et al.
Publicado: (2018) -
Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients
por: Zhan, Ming, et al.
Publicado: (2018) -
Effects of low-dose bufalin combined with hydroxycamptothecin on human castration-resistant prostate cancer xenografts in nude mice
por: Gu, Renze, et al.
Publicado: (2021) -
Establishment and Characterization of 7 Novel Hepatocellular Carcinoma Cell Lines from Patient-Derived Tumor Xenografts
por: Xin, Hong, et al.
Publicado: (2014)